Marketing of breast milk substitutes

Our commitment:
Market breast-milk substitutes responsibly

Our objectives

As part of our ongoing efforts to promote breastfeeding, report publicly on our progress regarding the responsible marketing of breast-milk substitutes.

By 2014 – Ensure our newly acquired Wyeth Nutrition Infant Formula business meets the FTSE4Good Index criteria.

Our progress

We are included in the FTSE4Good Index – the only global responsible investment index with clear criteria on the marketing of breast-milk substitutes (BMS). In 2013, our practices were audited in 31 countries by internal auditors and in three countries by Bureau Veritas. In light of the recommendations, we have enhanced our transparency and good governance mechanisms and strengthened our compliance systems.

We are committed to transparency, compliance and good governance. Taking part in the FTSE4Good assessment process demonstrates that commitment, and enables us to continuously improve our approach to the responsible marketing of breast-milk substitutes. Luis Cantarell, Head of Nestlé Nutrition

Our perspective

We believe breast-milk is the best food for infants, but there are still numerous barriers to breastfeeding, including inadequate maternity legislation. When, in consultation with their healthcare providers, mothers and families decide that optimal breastfeeding is not possible, infant formula – the only suitable BMS recognised by the WHO – plays a vital role in providing essential nutrients to infants. We are committed to the highest standards of responsible marketing of BMS and comply with the WHO Code as implemented by national governments. We will continue to engage with key stakeholders to increase collaboration, promote responsible conduct and establish an accepted and transparent process for assessing the commercialisation of BMS.

Related content

Find out more in our Creating Shared Value full report


In pictures: Supporting optimal infant nutrition